Evidence map›Paper›PMID 34203126›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Antibiogram Development in the Setting of a High Frequency of Multi-Drug Resistant Organisms at University Teaching Hospital, Lusaka, Zambia.

Brenna M Roth, Alexandra Laps, Kaunda Yamba, Emily L Heil, J Kristie Johnson, Kristen Stafford, Lottie M Hachaambwa, Mox Kalumbi, Lloyd Mulenga, Devang M Patel and 1 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Brenna M RothCenter for International Health, Education, and Biosecurity, University of Maryland School of Medicine, Baltimore, MD 21201, USA.ORCID 0000-0002-9721-7542
Alexandra LapsUniversity of Maryland School of Medicine, Baltimore, MD 21201, USA.
Kaunda YambaDepartment of Pathology and Microbiology, University Teaching Hospital, Lusaka 10101, Zambia.
Emily L HeilDepartment of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.ORCID 0000-0002-6644-6684
J Kristie JohnsonDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Kristen StaffordCenter for International Health, Education, and Biosecurity, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Lottie M HachaambwaCenter for International Health, Education, and Biosecurity, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Mox KalumbiDepartment of Pathology and Microbiology, University Teaching Hospital, Lusaka 10101, Zambia.
Lloyd MulengaDepartment of Medicine, University of Zambia School of Medicine, Lusaka 10101, Zambia.
Devang M PatelInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Cassidy W ClaassenCenter for International Health, Education, and Biosecurity, University of Maryland School of Medicine, Baltimore, MD 21201, USA.ORCID 0000-0001-5059-7894
University of Maryland, Baltimore · USUniversity Teaching Hospital · ZMMinistry of Health · ZM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance is a global challenge requiring reliable surveillance data collection and use. Prior studies on resistance in Zambia depended on laboratory methods with limited standardization. Since 2015, the University Teaching Hospital (UTH) microbiology laboratory has used the Vitek 2 Compact (bioMerieux, Inc., Marcy-l'Étoile, France) for standardized identification and susceptibility testing. We conducted a cross-sectional study of 2019 bacterial isolates collected from July 2015 to April 2017 to identify bacterial causes of infections, their susceptibility to commonly used antibiotics at UTH, and develop hospital antibiograms with a multidisciplinary team using World Health Organization guidance. We found high levels of antibiotic resistance among Gram negative bacteria.

Indexed as

antibiogramantimicrobial resistanceantimicrobial stewardshipbacteriamulti-drug resistant organismsZambia

Identifiers

PMID34203126
PMCPMC8300684
OpenAlexW3177484898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.